Global, regional, and national burden of anxiety‐related Alzheimer's disease and Alzheimer's‐related dementias among older adults from 1995 to 2021: A comparative risk assessment study
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-10 · 18 (4)
DOI: 10.1002/dad2.70537 ↗Abstract
Abstract INTRODUCTION This study aimed to quantify the global dementia burden attributable to anxiety disorders among older adults. Methods We searched PubMed, Embase, and MEDLINE through July, 2024 for cohort studies examining anxiety‐related dementia risk, and pooled risk ratios (RRs). Prevalence of anxiety disorders and disability‐adjusted life‐years (DALYs) for dementia were obtained from Global Burden of Disease (GBD) 2021. Attributable age‐standardized DALY rates (ASDRs) were estimated for 1995‐2021, with trends and cross‐country inequalities assessed. Results Fourteen studies met inclusion. Anxiety disorders were associated with increased dementia risk (RR: 1.14). Globally, attributable ASDRs declined slightly (23.54 to 22.52 per 100,000, 1995–2021). Highest burdens were observed in Europe and high‐middle sociodemographic index (SDI) regions in 2021, while the fastest increases occurred in South‐East Asian and low‐middle SDI regions. Global inequalities persisted over time. Discussion Anxiety contributes to dementia burden in older adults, highlighting the need for targeted interventions in countries and regions with high anxiety‐attributable dementia burden.
EUVIMED